key: cord-0746968-czd8swky
authors: Collins, Gary S.; Wilkinson, Jack
title: Statistical issues in the development of COVID‐19 prediction models
date: 2020-08-13
journal: J Med Virol
DOI: 10.1002/jmv.26390
sha: 7b5702f829b6795e9bbd7c5404d1734896c6c2fe
doc_id: 746968
cord_uid: czd8swky

Clinical prediction models to aid diagnosis, assess disease severity or prognosis have enormous potential to aid clinical decision making during the covid-19 pandemic. A living systematic review has, so far, identified 145 covid-19 prediction models published (or preprinted) between 03-January-2020 and 05-May-2020. Despite the considerable interest in developing covid-19 prediction models, the review concluded that all models to date, with no exception, are at high risk of bias with concerns related to data quality, flaws in the statistical analysis and poor reporting, and none are recommended for use. Disappointingly, the recent study by Yang and colleagues describing the development of a prediction model to identify covid-19 patients with severe disease, is no different. The study has failed to report important information needed to judge the study findings, but has numerous methodological concerns in design and analysis that deserve highlighting. This article is protected by copyright. All rights reserved.

To the Editor, Clinical prediction models to aid diagnosis, assess disease severity, or prognosis have enormous potential to aid clinical decision making during the coronavirus disease 2019 (COVID-19) pandemic. A living systematic review has, so far, identified 145 COVID-19 prediction models published (or preprinted) between 3 January and 5 May 2020. Despite the considerable interest in developing COVID-19 prediction models, the review concluded that all models to date, with no exception, are at high risk of bias with concerns related to data quality, flaws in the statistical analysis, and poor reporting, and none are recommended for use. 1 Disappointingly, the recent study by Yang et al 2 describing the development of a prediction model to identify COVID-19 patients with severe disease is no different. The study has failed to report important information needed to judge the study findings, but numerous methodological problems are apparent. 2 Our first point relates to the sample size. The sample size requirements in a prediction model study are largely influenced by the number of individuals experiencing the event to be predicted (in Yang's study, those with mild COVID-19 disease, as this is the smaller of the two outcome categories). Using published sample size formulae for developing prediction models, 3 Another concern is the actual model. The final model contains seven predictors and the authors have fully reported this permitting individualized prediction. However, an obvious and major concern is the regression coefficient reported for procalcitonin, with a value of 48.8309 and accompanying odds ratio with a confidence interval of ">999.999 (>999.999, >999.999)" (sic). This is clearly nonsensical, and to put it bluntly, makes the model unusable. The reason for the large regression value (standard error and confidence interval) is due to an issue called separation. 5 This occurred because there was little or no overlap in the procalcitonin values between individuals with mild and severe disease. The statistical software used by the authors, SAS, will report odds ratios as greater than 999 when this occurs. Instead of retaining this in the model as is, one preferred approach would be to use Firth's correction, available in both SAS and R5. The authors used the model to develop an early warning score-this score has not been presented by

Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal

A retrospective study on the epidemiological characteristics and establishment of an early warning system of severe COVID-19 patients

Calculating the sample size required for developing a clinical prediction model

Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating

Separation in logistic regression: causes, consequences, and control

Guide to presenting clinical prediction models for use in clinical settings

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis: the TRIPOD statement

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration